Clinically Significant Adverse Reactions: (Frequency unknown) Iris pigmentation: Since iris pigmentation may occur, patients should be examined regularly. If iris pigmentation occurs, use of this product may be discontinued according to patient's clinical condition.
Other Adverse Reactions: If any of the following symptoms or abnormalities is observed appropriate measures including discontinuation of treatment should be implemented. (See Table 2.)

View ADR Reporting Link